Logo image
Clinical outcomes of vitamin D deficiency and supplementation in cancer patients
Journal article   Peer reviewed

Clinical outcomes of vitamin D deficiency and supplementation in cancer patients

L Teleni, J Baker, B Koczwara, Michael G Kimlin, E Walpole, K Tsai and E A Isenring
Nutrition Reviews, Vol.71(9), pp.611-621
2013
url
https://doi.org/10.1111/nure.12047View
Published Version

Abstract

25-hydroxyvitamin D cancer cancer-specific outcomes cholecalciferol vitamin D deficiency
Results of recent studies suggest that circulating levels of vitamin D may play an important role in cancer-specific outcomes. The present systematic review was undertaken to determine the prevalence of vitamin D deficiency (<25nmol/L) and insufficiency (25-50nmol/L) in cancer patients and to evaluate the association between circulating calcidiol (the indicator of vitamin D status) and clinical outcomes. A systematic search of original, peer-reviewed studies on calcidiol at cancer diagnosis, and throughout treatment and survival, was conducted yielding 4,706 studies. A total of 37 studies met the inclusion criteria for this review. Reported mean blood calcidiol levels ranged from 24.7 to 87.4nmol/L, with up to 31% of patients identified as deficient and 67% as insufficient. The efficacy of cholecalciferol supplementation for raising the concentration of circulating calcidiol is unclear; standard supplement regimens of <1,000IU D3/day may not be sufficient to maintain adequate concentrations or prevent decreasing calcidiol. Dose-response studies linking vitamin D status to musculoskeletal and survival outcomes in cancer patients are lacking. © 2013 International Life Sciences Institute.

Details

Metrics

2 File views/ downloads
552 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Nutrition & Dietetics

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image